Skip to main content
Top
Published in: Clinical Sarcoma Research 1/2014

Open Access 01-12-2014 | Case Report

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients

Authors: Lea N Baer, David G Savage, Hanina H Hibshoosh, Kevin Kalinsky

Published in: Clinical Sarcoma Research | Issue 1/2014

Login to get access

Abstract

An increased risk of posttransplant malignancy has been consistently reported following various solid organ transplants. The malignancies most commonly encountered are non-melanoma skin cancers, carcinomas of lung or breast and posttransplant lymphoproliferative disorders. Angiosarcoma, an uncommon vascular mesenchymal neoplasm, is rare in the posttransplant setting. This report describes two patients who developed high-grade angiosarcoma following a solid organ transplant. Notably, in both patients, the diagnosis of angiosarcoma was preceded by diagnosis of a lymphoproliferative disorder with monoclonal immunoglobulin heavy chain rearrangement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zafar SY, Howell DN, Gockerman JP: Malignancy after solid organ transplantation: an overview. Oncologist. 2008, 13: 769-778. 10.1634/theoncologist.2007-0251CrossRefPubMed Zafar SY, Howell DN, Gockerman JP: Malignancy after solid organ transplantation: an overview. Oncologist. 2008, 13: 769-778. 10.1634/theoncologist.2007-0251CrossRefPubMed
2.
go back to reference Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant. 2004, 4: 905-913. 10.1111/j.1600-6143.2004.00450.xCrossRefPubMed Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant. 2004, 4: 905-913. 10.1111/j.1600-6143.2004.00450.xCrossRefPubMed
4.
go back to reference Sheil AG: Cancer in immune-suppressed organ transplant recipients: aetiology and evolution. Transplant Proc. 1998, 30: 2055-2057. 10.1016/S0041-1345(98)00539-9CrossRefPubMed Sheil AG: Cancer in immune-suppressed organ transplant recipients: aetiology and evolution. Transplant Proc. 1998, 30: 2055-2057. 10.1016/S0041-1345(98)00539-9CrossRefPubMed
5.
go back to reference Jensen MK: Chromosome studies in patients treated with azathioprine and amethopterin. Acta Med Scand. 1967, 182: 445-455.CrossRefPubMed Jensen MK: Chromosome studies in patients treated with azathioprine and amethopterin. Acta Med Scand. 1967, 182: 445-455.CrossRefPubMed
6.
go back to reference Rosenthal AK, Klausmeier M, Cronin ME, McLaughlin JK: Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature. Am J Clin Oncol. 2000, 23: 581-583. 10.1097/00000421-200012000-00010CrossRefPubMed Rosenthal AK, Klausmeier M, Cronin ME, McLaughlin JK: Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature. Am J Clin Oncol. 2000, 23: 581-583. 10.1097/00000421-200012000-00010CrossRefPubMed
7.
go back to reference Gutierrez-Dalmau A, Campistol JM: Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007, 67: 1167-1198. 10.2165/00003495-200767080-00006CrossRefPubMed Gutierrez-Dalmau A, Campistol JM: Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007, 67: 1167-1198. 10.2165/00003495-200767080-00006CrossRefPubMed
8.
go back to reference Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF: Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996, 77: 2400-2406. 10.1002/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-ZCrossRefPubMed Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF: Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996, 77: 2400-2406. 10.1002/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-ZCrossRefPubMed
9.
go back to reference Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP, Desphpande V, Suit HD, DeLaney TF, Yoon SS: Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007, 14: 1953-1967. 10.1245/s10434-006-9335-yCrossRefPubMed Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP, Desphpande V, Suit HD, DeLaney TF, Yoon SS: Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007, 14: 1953-1967. 10.1245/s10434-006-9335-yCrossRefPubMed
10.
go back to reference Tahir M, Hendry P, Baird L, Qureshi NA, Ritchie D, Whitford P: Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery. Int Semin Surg Oncol. 2006, 3: 26- 10.1186/1477-7800-3-26PubMedCentralCrossRefPubMed Tahir M, Hendry P, Baird L, Qureshi NA, Ritchie D, Whitford P: Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery. Int Semin Surg Oncol. 2006, 3: 26- 10.1186/1477-7800-3-26PubMedCentralCrossRefPubMed
11.
go back to reference Ward JR, Feigenberg SJ, Mendenhall NP, Marcus RB, Mendenhall WM: Radiation therapy for angiosarcoma. Head Neck. 2003, 25: 873-878. 10.1002/hed.10276CrossRefPubMed Ward JR, Feigenberg SJ, Mendenhall NP, Marcus RB, Mendenhall WM: Radiation therapy for angiosarcoma. Head Neck. 2003, 25: 873-878. 10.1002/hed.10276CrossRefPubMed
12.
go back to reference Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet. 1997, 350: 1647-1654.CrossRef Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet. 1997, 350: 1647-1654.CrossRef
13.
go back to reference Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS: An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013, 24: 257-263. 10.1093/annonc/mds237CrossRefPubMed Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS: An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013, 24: 257-263. 10.1093/annonc/mds237CrossRefPubMed
14.
go back to reference Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JE: Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008, 26: 5269-5274. 10.1200/JCO.2008.17.3146CrossRefPubMed Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JE: Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008, 26: 5269-5274. 10.1200/JCO.2008.17.3146CrossRefPubMed
15.
go back to reference Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB: De novo tumors after liver transplantation: a single-institution experience. Liver Transpl. 2002, 8: 285-291. 10.1053/jlts.2002.29350CrossRefPubMed Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB: De novo tumors after liver transplantation: a single-institution experience. Liver Transpl. 2002, 8: 285-291. 10.1053/jlts.2002.29350CrossRefPubMed
16.
go back to reference Webster P, Wujanto L, Fisher C, Walker M, Ramakrishnan R, Naresh K, Thomas JM, Papalois V, Crane J, Taube D, Duncan N: Malignancies confined to disused arteriovenous fistulae in renal transplant patients: an important differential diagnosis. Am J Nephrol. 2011, 34: 42-48. 10.1159/000328908CrossRefPubMed Webster P, Wujanto L, Fisher C, Walker M, Ramakrishnan R, Naresh K, Thomas JM, Papalois V, Crane J, Taube D, Duncan N: Malignancies confined to disused arteriovenous fistulae in renal transplant patients: an important differential diagnosis. Am J Nephrol. 2011, 34: 42-48. 10.1159/000328908CrossRefPubMed
17.
go back to reference Gyulai R, Kemeny L, Kiss M, Nagy S, Adam E, Nagy F, Dobozy A: Human herpesvirus 8 DNA sequences in angiosarcoma of the face. Br J Dermatol. 1997, 137: 467- 10.1111/j.1365-2133.1997.tb03761.xCrossRefPubMed Gyulai R, Kemeny L, Kiss M, Nagy S, Adam E, Nagy F, Dobozy A: Human herpesvirus 8 DNA sequences in angiosarcoma of the face. Br J Dermatol. 1997, 137: 467- 10.1111/j.1365-2133.1997.tb03761.xCrossRefPubMed
18.
go back to reference Lebbe C, Pellet C, Flageul B, Sastre X, Avril MF, Bonvalet D, Morel P, Calvo F: Sequences of human herpesvirus 8 are not detected in various non-Kaposi sarcoma vascular lesions. Arch Dermatol. 1997, 133: 919-920. 10.1001/archderm.1997.03890430141027CrossRefPubMed Lebbe C, Pellet C, Flageul B, Sastre X, Avril MF, Bonvalet D, Morel P, Calvo F: Sequences of human herpesvirus 8 are not detected in various non-Kaposi sarcoma vascular lesions. Arch Dermatol. 1997, 133: 919-920. 10.1001/archderm.1997.03890430141027CrossRefPubMed
19.
go back to reference Lebbe C, Tatoud R, Morel P, Calvo F, Euvrard S, Kanitakis J, Faure M, Claudy A: Human herpesvirus 8 sequences are not detected in epithelial tumors from patients receiving transplants. Arch Dermatol. 1997, 133: 111-PubMed Lebbe C, Tatoud R, Morel P, Calvo F, Euvrard S, Kanitakis J, Faure M, Claudy A: Human herpesvirus 8 sequences are not detected in epithelial tumors from patients receiving transplants. Arch Dermatol. 1997, 133: 111-PubMed
Metadata
Title
Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients
Authors
Lea N Baer
David G Savage
Hanina H Hibshoosh
Kevin Kalinsky
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Clinical Sarcoma Research / Issue 1/2014
Electronic ISSN: 2045-3329
DOI
https://doi.org/10.1186/2045-3329-4-15

Other articles of this Issue 1/2014

Clinical Sarcoma Research 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine